| Dr Mark Neagle, MD | |
|
2121 E Harmony Rd, Suite 300, Fort Collins, CO 80528-3400 | |
| (970) 224-9102 | |
| (970) 224-9112 |
| Full Name | Dr Mark Neagle |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 27 Years |
| Location | 2121 E Harmony Rd, Fort Collins, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699745539 | NPI | - | NPPES |
| 82877262 | Medicaid | CO | |
| 121520500 | Medicaid | WY | |
| P00244105 | Other | CO | RAILROAD MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Poudre Valley Hospital | Fort collins, CO | Hospital |
| Medical Center Of The Rockies | Loveland, CO | Hospital |
| Estes Park Medical Center | Estes park, CO | Hospital |
| Uchealth Greeley Hospital | Greeley, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Poudre Valley Medical Group Llc | 9638208549 | 1605 |
| Poudre Valley Medical Group Llc | 9638208549 | 1605 |
News Archive
"No one can figure out a politically acceptable way to pay for an overhaul of America's health care system, and until someone does, the effort is stalled. Maybe indefinitely," McClatchy reports. Michael Tanner, a "health care analyst" at the Cato Institute, says "it's quite feasible that the whole thing could crash and burn because of sticker shock."
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.
With the support of a Major League Baseball star, a new University of Florida research center on an island settled by the Vikings could lead to breakthroughs about a rare genetic disorder and potentially change the course of care for high blood pressure and other common conditions.
German researchers have found a significant association of IL28B genotypes to interferon-based antiviral treatment outcome, and to graft inflammation caused by hepatitis C virus (HCV). The study determined that the presence of G-allele serves as a marker for severe HCV-induced graft inflammation, as well as a predictor for unsuccessful treatment.
Today Bruker launched the new ALPHA II, the latest generation of the ALPHA series of compact FTIR spectrometers. The ALPHA II features fully-automated test routines for validation regarding operational qualification and performance validation as well as innovations in temperature-stabilized detector and high-quality IR source technology.
› Verified 4 days ago
| Entity Name | Poudre Valley Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366763260 PECOS PAC ID: 9638208549 Enrollment ID: O20100602000122 |
News Archive
"No one can figure out a politically acceptable way to pay for an overhaul of America's health care system, and until someone does, the effort is stalled. Maybe indefinitely," McClatchy reports. Michael Tanner, a "health care analyst" at the Cato Institute, says "it's quite feasible that the whole thing could crash and burn because of sticker shock."
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.
With the support of a Major League Baseball star, a new University of Florida research center on an island settled by the Vikings could lead to breakthroughs about a rare genetic disorder and potentially change the course of care for high blood pressure and other common conditions.
German researchers have found a significant association of IL28B genotypes to interferon-based antiviral treatment outcome, and to graft inflammation caused by hepatitis C virus (HCV). The study determined that the presence of G-allele serves as a marker for severe HCV-induced graft inflammation, as well as a predictor for unsuccessful treatment.
Today Bruker launched the new ALPHA II, the latest generation of the ALPHA series of compact FTIR spectrometers. The ALPHA II features fully-automated test routines for validation regarding operational qualification and performance validation as well as innovations in temperature-stabilized detector and high-quality IR source technology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Neagle, MD 2121 E Harmony Rd, Suite 300, Fort Collins, CO 80528-3400 Ph: (970) 224-9102 | Dr Mark Neagle, MD 2121 E Harmony Rd, Suite 300, Fort Collins, CO 80528-3400 Ph: (970) 224-9102 |
News Archive
"No one can figure out a politically acceptable way to pay for an overhaul of America's health care system, and until someone does, the effort is stalled. Maybe indefinitely," McClatchy reports. Michael Tanner, a "health care analyst" at the Cato Institute, says "it's quite feasible that the whole thing could crash and burn because of sticker shock."
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.
With the support of a Major League Baseball star, a new University of Florida research center on an island settled by the Vikings could lead to breakthroughs about a rare genetic disorder and potentially change the course of care for high blood pressure and other common conditions.
German researchers have found a significant association of IL28B genotypes to interferon-based antiviral treatment outcome, and to graft inflammation caused by hepatitis C virus (HCV). The study determined that the presence of G-allele serves as a marker for severe HCV-induced graft inflammation, as well as a predictor for unsuccessful treatment.
Today Bruker launched the new ALPHA II, the latest generation of the ALPHA series of compact FTIR spectrometers. The ALPHA II features fully-automated test routines for validation regarding operational qualification and performance validation as well as innovations in temperature-stabilized detector and high-quality IR source technology.
› Verified 4 days ago
Dr. Stephen A Treat, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2121 E Harmony Rd, Ste 100, Fort Collins, CO 80528 Phone: 970-221-1000 Fax: 970-297-6844 | |
Dr. David Kindley Cobb, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2121 E Harmony Rd Unit 380, Fort Collins, CO 80528 Phone: 970-224-0429 | |
Dr. Diana M Breyer, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2121 E Harmony Rd, Suite 300, Fort Collins, CO 80528 Phone: 970-224-9102 Fax: 970-224-9112 | |
Fred H Meyer, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 219 S Sunset St, Fort Collins, CO 80521 Phone: 970-224-2156 Fax: 970-482-6936 | |
Robert A Simmons, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3702 S Timberline Rd, Fort Collins, CO 80525 Phone: 970-207-9773 Fax: 970-207-1893 | |
Dr. Charles Timothy Johnson, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2121 E Harmony Rd, Unit 100, Fort Collins, CO 80528 Phone: 970-221-1000 Fax: 970-297-6860 | |
Dr. Elizabeth A Yoder, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 Fax: 970-472-9381 |